Product References and Citations for NF023, inhibitor
Bouchaa¯b El Bahh, Silvia Balosso, Trevor Hamilton, et al. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. European Journal of Neuroscience, 2005, 22: 1417-1430.
Bouchaa¯b El Bahh, Silvia Balosso, Trevor Hamilton, et al. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. European Journal of Neuroscience, 2005, 22: 1417-1430.
Daniela Proske, Martin Hofliger, Richard M. Soll, et al. A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y. The Journal of Biological Chemistry, 2002, 277(13):11416-11422.
Daniela Proske, Martin Hofliger, Richard M. Soll, et al. A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y. The Journal of Biological Chemistry, 2002, 277(13):11416-11422.
Philip J. Medeirosa and Dwayne N. Jackson. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Peptides, 2013, 48:106-113.
Philip J. Medeirosa and Dwayne N. Jackson. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Peptides, 2013, 48:106-113.
Valentina Corvino, Elisa Marchese, Stefano Giannetti, et al. The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J. Neurochem., 2012, 122: 415-426.
Valentina Corvino, Elisa Marchese, Stefano Giannetti, et al. The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J. Neurochem., 2012, 122: 415-426.